期刊
ANTIOXIDANTS
卷 10, 期 12, 页码 -出版社
MDPI
DOI: 10.3390/antiox10121958
关键词
hyperglycemia; IL-6; insulin resistance; neuroinflammation; stroke
资金
- Ministry of Science and Technology [MOST 105-2314-B-075A-004-MY3, MOST 105-2314-B-075A-006-MY3]
- Taichung Veterans General Hospital [TCVGH-1108201C, TCVGH-HK1098001]
- Central Region Hospital Alliance (Ministry of Health and Welfare)
- Feng Yuan Hospital, Taiwan
This study demonstrated that the use of Jak2 inhibitor AG490 can improve neurological deficits, reduce inflammation and oxidative stress, and decrease brain infarction in stroke rats. AG490 was also found to mitigate IL-6-induced endothelial barrier disruption, lower blood glucose levels, improve glucose tolerance, and reduce inflammation in peripheral tissues.
Poststroke hyperglycemia and inflammation have been implicated in the pathogenesis of stroke. Janus Kinase 2 (Jak2), a catalytic signaling component for cytokine receptors such as Interleukin-6 (IL-6), has inflammatory and metabolic properties. This study aimed to investigate the roles of Jak2 in poststroke inflammation and metabolic abnormality in a rat model of permanent cerebral ischemia. Pretreatment with Jak2 inhibitor AG490 ameliorated neurological deficit, brain infarction, edema, oxidative stress, inflammation, caspase-3 activation, and Zonula Occludens-1 (ZO-1) reduction. Moreover, in injured cortical tissues, Tumor Necrosis Factor-alpha, IL-1 beta, and IL-6 levels were reduced with concurrent decreased NF-kappa B p65 phosphorylation, Signal Transducers and Activators of Transcription 3 phosphorylation, Ubiquitin Protein Ligase E3 Component N-Recognin 1 expression, and Matrix Metalloproteinase activity. In the in vitro study on bEnd.3 endothelial cells, AG490 diminished IL-6-induced endothelial barrier disruption by decreasing ZO-1 decline. Metabolically, administration of AG490 lowered fasting glucose, with improvements in glucose intolerance, plasma-free fatty acids, and plasma C Reactive Proteins. In conclusion, AG490 improved the inflammation and oxidative stress of neuronal, hepatic, and muscle tissues of stroke rats as well as impairing insulin signaling in the liver and skeletal muscles. Therefore, Jak2 blockades may have benefits for combating poststroke central and peripheral inflammation, and metabolic abnormalities.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据